Does the Osteoporosis Dose of Denosumab Really Cause Clinically Significant Hypocalcaemia in CKD 4 and 5
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 2
Abstract
Denosumab is a potent novel antiresorptive agent for treatment of osteoporosis with unique mechanism of action . It is a fully human monoclonal antibody to the receptor activator of nuclear factor-κB ligand (RANKL) that blocks its binding to RANK, inhibiting the development and activity of osteoclasts, decreasing bone resorption, and increasing bone density. Initially denosumab appeared particularly promising for patients with advanced stages of renal failure but over the past two years several publications questioned that, reporting adverse effects and especially severe hypocalcaemia. Aim of the Study: to investigate further the effect of the osteoporosis dose of denosumab on serum calcium levels in patients with CKD 4 and CKD 5. Methods: This retrospective outpatient study included 17 females with CKD 4 and 5 who received a single or a multiple (at 6 months intervals) 60-mg subcutaneous dose of denosumab. Adjusted serum Calcium was measured prior to the dose and at various points of time after that. Results: Only two of the subjects developed clinically significant hypocalcaemia. Both of them were clearly inadequately supplemented with calcium and vitamin D. Conclusion: The results from the current study along with a critical analysis of the previous publications reveal that the vast majority of the previous reports were based on inadequately supplemented with calcium and vitamin D patients and that severe hypocalcaemia is unlikely in appropriately supplemented subjects, especially in the CKD 4 subgroup. However, due to the scarcity of data further research is warranted, especially in the CKD 5 subgroup. In the mean time more cautious approach rather than a blanket ban on denosumab appears to be the most appropriate policy in these two populations.
Authors and Affiliations
Petko Ivanov
Keywords
Related Articles
- EP ID EP348497
- DOI 10.9734/BJMMR/2014/6300
- Views 44
- Downloads 0
Platelet Rich Fibrin and Nanocrystalline Hydroxyapatite with Collagen Combination in Treatment of Periapical Lesion: A Novel Clinical Approach
Aims: To use platelet rich fibrin (PRF), which is an autologous platelet concentrate, along with nanocrystalline hydroxyapatite with collagen for treatment of periapical lesion and negotiation of calcified canal of adjac...
Prevention of Anastomotic Leakage in Gastrointestinal Tract: A Brief Literature Review
Anastomotic leakage and its consequences in gastrointestinal tract surgery, especially in low anterior resection, is a day major complication affecting morbidity and mortality rate. Early detection and prevention is cruc...
Comparative Effectiveness of Chemical, Biological or Combination of Both Mosquito Larvicides for Dengue Control in George Town, Penang, Malaysia – A Field Trial
Background: Tackling the increasing trend of the dengue menace remains one of the most challenging tasks in public health medicine. Extensive literature search revealed no previous community intervention trial done in Pe...
Risk Factors Associated with Diabetes Mellitus among Adults in the Hohoe Municipality of Ghana
Background: Diabetes Mellitus (DM), one of the Non-Communicable Diseases (NCDs) is a major cause of morbidity and mortality worldwide and is increasingly becoming an important public health concern. This study examined t...
Neck Circumference as a Novel Anthropometric Value for Diagnosis of Metabolic Syndrome and Obesity in Patients with Diabetes
Background and Objective: Metabolic syndrome and obesity are known as important risk factors for cardiovascular disease which have a high frequency among diabetic patients. Central obesity in metabolic syndrome diagnosti...